Supplementation with Bifidobacterium animalis subsp. lactis MH-022 for Remission of Motor Impairments in a 6-OHDA-Induced Parkinson's Disease Rat Model by Reducing Inflammation, Reshaping the Gut Microbiome, and Fostering Specific Microbial Taxa

Inflammation significantly influences the degeneration of dopaminergic neurons in Parkinson's disease (PD), which is potentially intensified by associated gut dysbiosis. The therapeutic potential of probiotics, due to their antioxidant, anti-inflammatory, and gut microbiota modulatory properties, is explored herein as a means to improve gut health and influence the gut-brain-microbiota axis in the context of PD. In this study, we investigated the role and possible mechanism of